Price (INR)28,235.55 Today's Change-214.65 / -0.75% Shares traded10.67k 1 Year change+9.94% Beta0.1036 Data delayed at least 15 minutes, as of Jan 14 2025 10:01 GMT. Find More Stocks Use our equities screener to discover other potential opportunities. Find Stocks Similar to ABBOTINDIAGo...
Abbott Laboratories stock price (ABT) in USD Buying or selling a stock that’s not traded in your local currency? Don’t let the currency conversion trip you up. Convert Abbott Laboratories stocks or shares into any currency with our handy tool, and you’ll always know what you’re getting...
Thanks Mike. Good morning, everyone and thank you for joining us. Today, we reported second quarter adjusted earnings per share of $1.08, which reflects an acceleration in the contribution from the underlying base business. Organic sales, excluded COVID testing, increased low double-digits for th...
It seemed crazy to many, but White perceived that developing new drugs had a completely different business rhythm than what the new Abbott would now focus on: devices, diagnostics, nutritional products and branded generic drugs. The result: Abbott's stock has since risen from 24 a share to a...
Thanks, Scott. Good morning, everyone, and thank you for joining us. Today, I'll discuss our 2022 results as well as our outlook for this year. For the full-year 2022, we achieved ongoing earnings per share of $5.34, which is well above the original EPS guidance we set at the beginn...
Today we reported another highly successful year for Abbott during what’s been the single most disruptive healthcare event in our lifetimes. For the full year, we reported organic sales growth of nearly 10% and ongoing earnings per share of $3.65, which reflects double-digit growth and is at...
Thanks, Scott. Good morning, everyone, and thank you for joining us. Today, we reported results of another strong quarter, including ongoing earnings per share of $1.15. Based on our performance through the first nine months of the year, we increased our full year adjusted earnings per share...
So the flip side of that is, competition is — you could potentially see I guess price as a lever to drive demand or to drive share capture. We’ve tried to focus every time we’re entering markets with a value proposition that sustains our pricing strategy and focus on the benefits tha...
a non-employee director will receive one Abbott common share for each restricted stock unit. In addition, the restrictions on transfer were removed from the Abbott shares that had previously been issued under the program and from the shares of Hospira received as a dividend with respect to those...
Today, we issued guidance for full year adjusted earnings per share of at least $5. Based on current rates, we would expect exchange to have a favorable impact of approximately 3.5% on our reported sales which includes an expected favorable impact of approximately 3% on our first quarter ...